查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1962556

血液採集管機械市場：依操作模式、技術、管型、最終用戶和應用分類－全球預測，2026-2032年

Blood Collection Tube Machines Market by Operation Mode, Technology, Tube Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血液採集管製造設備市場價值將達到 7.7137 億美元，到 2026 年將成長至 8.3067 億美元，到 2032 年將達到 12.2793 億美元，複合年成長率為 6.86%。

主要市場統計數據
基準年 2025 7.7137億美元
預計年份：2026年 8.3067億美元
預測年份 2032 1,227,930,000 美元
複合年成長率 (%) 6.86%

全面概述影響血液採集管機採購和實施的不斷變化的臨床、營運和監管因素。

血液採集管處理系統市場處於臨床需求、檢查室效率和嚴格監管要求的交匯點，這要求相關人員在處理能力需求與準確性、安全性和可追溯性之間取得平衡。隨著檢查室自動化技術的進步和對檢體完整性的日益重視，能夠可靠處理各種類型試管、與實驗室資訊系統整合並支援嚴格的品管流程的設備的重要性日益凸顯。隨著臨床路徑朝向分散式和高通量檢測方向發展，操作人員必須評估能夠平衡效能、擁有成本和供應商服務能力的設備。

對關鍵變革性技術、供應鏈和監管趨勢進行詳細分析，以重新定義產品藍圖和臨床部署模式。

近年來，臨床採血管裝置的規格、製造和應用方式發生了翻天覆地的變化。裝置製造商正在將數位感測器和連接功能融入其中，實現裝置即時健康診斷、檢體追蹤以及與實驗室資訊系統的整合，從而使裝置從單純的機械功能轉變為互聯平台。同時，自動化趨勢推動了封閉式工作流程的發展，減少了人為接觸，提高了生物安全性，使得自動化解決方案在高通量操作中越來越受歡迎。而在資源受限的環境中，半自動化系統仍保持著一定的市場需求。

對新的關稅結構如何重塑全球供應鏈、籌資策略和各行業的製造地地點進行深入調查。

2025年實施的新關稅措施引入了新的結構性變量，影響產業的採購經濟性、供應鏈設計和策略採購。關稅造成的成本差異迫使製造商重新評估其全球生產地點，並考慮將關鍵子組件的生產外包到近岸地區，以保持價格競爭力並縮短前置作業時間。因此，買賣雙方的談判擴大包含有關關稅應急措施、成本轉嫁機制以及庫存和物流風險共擔安排的條款。

策略性細分洞察揭示了操作模式、感測技術、管道配置、最終用戶需求和應用如何決定採購和產品設計優先順序。

市場區隔揭示了不同的需求促進因素，並明確了每種操作模式、技術類型、管路類型、終端用戶環境和臨床應用的產品適用性要求。專為自動化操作設計的儀器面向高通量檢查室優先考慮最大限度地減少人工干預並與下游分析儀無縫整合。另一方面，半自動儀器在重視靈活手動監控的人員配置模式中，或在資金限制無法投資全自動化的環境中仍然非常重要。機械、光學和壓力技術各有優缺點：機械系統在基本灌裝檢測方面具有穩健性和低複雜性；光學模式可實現非接觸式監控和增強的檢體檢驗；壓力感測器可快速定量評估管路容積和真空狀態。非真空管路和真空管路的選擇會影響儀器配置和耗材管理。標準化採樣工作流程通常需要真空管路，而非真空管路則用於特殊或資源受限的環境。

從全面的區域觀點出發，重點介紹美洲、歐洲、中東和非洲以及亞太市場在採用促進因素、監管環境和採購行為方面的差異。

區域趨勢反映了臨床基礎設施、管理體制和採購實踐方面的差異，這些差異會影響產品應用和商業策略。在美洲，先進的臨床檢查室和集中式檢測網路正在推動對具備強大售後服務和整合能力的高通量自動化系統的需求。該地區重視快速創新週期和數位化醫療的普及，這為優先考慮連接性、分析和生命週期服務的解決方案提供了機遇，從而最大限度地提高運作和效率。

深入的企業級分析，著重於透過整合解決方案、卓越服務、夥伴關係和智慧財產權策略來實現差異化。

該行業的競爭動態著重於差異化的產品系列、服務深度以及提供整合工作流程的能力，而非獨立設備。領先的製造商憑藉其在與檢測設備和資訊系統經過檢驗的整合、久經考驗的現場可靠性以及包括安裝、預防性保養和備件物流在內的快速售後服務方面的優勢展開競爭。與耗材供應商和契約製造建立策略合作夥伴關係，可以加快新設備型號的上市速度。同時，對感測器技術、樣品處理演算法和軟體檢驗等相關智慧財產權的投資，能夠建構起可抵禦競爭的競爭優勢。

為製造商和買家提供可操作且優先考慮的建議，以改善互通性、供應鏈韌性、服務模式、監管合規性和永續性成果。

產業領導者應推動一系列切實有效的舉措，使產品開發與營運實際情況和買家期望相契合。優先投資於互通性和安全資料交換，並確保設備與實驗室資訊系統和下游分析平台無縫整合，將提升高通量檢查室和醫院網路的價值。同時，應實現製造和籌資策略多元化，以降低關稅相關的成本波動風險，並縮短關鍵零件和備件的前置作業時間。兼顧互聯互通和供應鏈韌性，將有助於減少採購摩擦，並提升長期競爭力。

我們將以透明的方式解釋我們的混合方法研究途徑，該方法結合了專家訪談、標準審查、供應鏈映射和檢驗研討會，以確保獲得可靠的見解。

本調查方法結合了定性和定量技術，旨在全面了解技術、採購和營運環境。調查的第一階段包括對實驗室經理、血庫管理人員、醫院採購負責人、醫療設備工程師和法規專家進行結構化訪談，以確定實際限制、檢驗要求和實施重點。第二階段整合了產品文件、標準文件、臨床指南和公開的法規判例，以闡明器械設計選擇和上市後義務的背景。

簡潔扼要的總結強調了產品完整性、互通性、供應彈性和分階段部​​署的策略要求，以最大限度地發揮臨床影響。

總之，自動化血液採集管處理系統是實現臨床診斷、血庫、法醫學分析和調查應用中安全、高效且可追溯的檢體工作流程的關鍵基礎技術。選擇合適的系統需要對自動化程度、感測技術、試管相容性、互通性和服務保障進行全面評估。考慮到區域和應用方面的差異，客製化產品和靈活的商業模式對於滿足高通量集中式檢查室和分散式臨床環境的需求至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：市場運作

  • 自動的
  • 半自動

第9章 血液採集管機械市場：依技術分類

  • 機械的
  • 光學的
  • 壓力

第10章：按管型分類的採血管機械市場

  • 非真空型
  • 真空型

第11章 採血管機械市場：依最終用戶分類

  • 血庫
  • 檢查室
  • 醫院

第12章 採血管機械市場：依應用領域分類

  • 臨床診斷
  • 法醫學
  • 調查

第13章：採血管機械市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：採血管機械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 採血管機械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國採血管機械市場

第17章：中國採血管機械市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Ajosha Bio Teknik Pvt. Ltd.
  • Becton, Dickinson and Company
  • Biomall
  • Bio-x Diagnostics
  • CDRICH Corporation
  • CML Biotech Ltd.
  • Danaher Corporation
  • Gong Dong Medical
  • GPC Medical, Ltd.
  • Hawach Scientific Co., Ltd.
  • KS Medical
  • Medtronic plc
  • Narang Medical Limited
  • Nipro Corporation
  • Qiagen NV
  • Quantum Biomedicals
  • Roche Holding AG
  • Sanli Medical
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • TUD Corporation
Product Code: MRR-0A38069518BF

The Blood Collection Tube Machines Market was valued at USD 771.37 million in 2025 and is projected to grow to USD 830.67 million in 2026, with a CAGR of 6.86%, reaching USD 1,227.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 771.37 million
Estimated Year [2026] USD 830.67 million
Forecast Year [2032] USD 1,227.93 million
CAGR (%) 6.86%

Comprehensive introduction to the evolving clinical, operational, and regulatory forces shaping procurement and deployment of blood collection tube machines

The blood collection tube machine landscape sits at the intersection of clinical demand, laboratory efficiency, and regulatory rigor, requiring stakeholders to reconcile throughput requirements with precision, safety, and traceability. Advances in laboratory automation and focus on specimen integrity have increased the importance of devices that reliably process a wide range of tube types, integrate with laboratory information systems, and support rigorous quality control workflows. As clinical pathways evolve toward decentralized and high-volume testing, operators must evaluate equipment that balances performance with cost of ownership and vendor service capabilities.

In parallel, manufacturers face intensifying expectations for device interoperability, digital connectivity, and compliance with evolving standards for medical devices and diagnostics. The procurement community now emphasizes lifecycle support, spare parts availability, and validated consumables compatibility as part of total value assessments. Consequently, strategic planning must incorporate operational continuity, supply chain resilience, and the capacity to adapt machines to both established and emergent sample collection protocols. Together, these dynamics shape procurement choices and long-term capital allocation for laboratories, hospitals, and blood banks.

In-depth analysis of major transformative technological, supply chain, and regulatory shifts that are redefining product roadmaps and clinical adoption patterns

Recent years have produced a wave of transformative shifts that alter how blood collection tube machines are specified, manufactured, and adopted across clinical settings. Device makers increasingly embed digital sensors and connectivity to provide real-time diagnostics of device health, sample tracking, and integration with laboratory information systems, moving beyond isolated mechanical functions toward connected platforms. Concurrently, automation trends favor closed workflows that reduce human touchpoints and improve biosafety, making automatic solutions more attractive for high-volume operations while semi-automatic systems retain appeal in constrained-resource environments.

Material innovation and precision engineering have improved compatibility with both vacuum and non-vacuum tube formats, while new sensing modalities-mechanical, optical, and pressure-based-enhance detection of fill volume and clot formation. Sustainability concerns have catalyzed research into recyclable components and reduced single-use waste, prompting manufacturers to rethink consumables and service models. Moreover, geopolitical shifts and supply chain reconfiguration accelerate localization strategies and diversified supplier networks. Regulatory pathways are also adapting to the digitalization of devices, with increased scrutiny on cybersecurity, data integrity, and software validation, which in turn informs product roadmaps and post-market surveillance obligations. Together, these shifts require integrated responses from manufacturers, clinical leaders, and procurement teams.

Thorough exploration of how new tariff structures are reshaping global supply chains, procurement strategies, and manufacturing footprints across the industry

The introduction of new tariff measures in 2025 has introduced another structural variable affecting procurement economics, supply chain design, and strategic sourcing in the industry. Tariff-driven cost differentials have compelled manufacturers to reassess global production footprints and to consider nearshoring for critical subassemblies to preserve competitive pricing and shorten lead times. As a result, buyer-supplier negotiations increasingly include clauses that address tariff contingencies, cost pass-through mechanisms, and joint risk-sharing arrangements for inventory and logistics.

In response, clinical operators and distributors have started to incorporate scenario planning into purchasing cycles, emphasizing supplier diversification and longer inventory horizons for critical spare parts. Contract manufacturers and original equipment manufacturers are evaluating shifts in contractual terms and sourcing strategies to mitigate tariff exposure, including seeking alternative materials, qualifying secondary suppliers, and accelerating investments in automated, scalable manufacturing lines closer to major demand centers. Over time, these adjustments will shape product availability, after-sales support geography, and strategic partnerships across the value chain. While tariffs create near-term cost pressure, they also stimulate structural adaptation that can enhance resilience and foster regional manufacturing ecosystems over the longer term.

Strategic segmentation insights revealing how operation modes, sensing technologies, tube formats, end-user needs, and applications determine procurement and product design priorities

Segmentation reveals differentiated demand drivers and distinct product-fit requirements across operation modes, technology types, tube formats, end-user environments, and clinical applications. Devices designed for automatic operation target high-throughput laboratories that prioritize minimal manual intervention and seamless integration with downstream analyzers, while semi-automatic machines retain importance where staffing models favor flexible manual oversight and where capital expenditure constraints limit full automation investments. Mechanical, optical, and pressure-based technologies each present trade-offs: mechanical systems offer robustness and lower complexity for basic fill detection, optical modalities enable non-contact monitoring and enhanced sample verification, and pressure sensors provide rapid, quantitative assessment of tube fill and vacuum integrity. The choice between non-vacuum and vacuum tube types affects device configuration and consumables handling, with vacuum tubes often demanded for standardized collection workflows and non-vacuum formats used in specialized or resource-limited settings.

End users demonstrate varied priorities that influence procurement criteria. Blood banks emphasize chain-of-custody, sample integrity, and biocontainment features, diagnostic laboratories prioritize throughput, automation compatibility, and data integration, while hospitals balance clinical flexibility with bedside workflow constraints and infection control considerations. Application contexts further refine requirements: clinical diagnostics demand rigorous validation and consistent throughput, forensic applications require enhanced traceability and tamper-evidence, and research environments favor modularity and adaptability for diverse study protocols. Understanding these segmentation axes enables vendors and purchasers to align product capabilities with operational needs, craft differentiated value propositions, and prioritize development roadmaps that meet the nuanced expectations of each customer cohort.

Comprehensive regional perspectives highlighting divergent adoption drivers, regulatory landscapes, and procurement behaviors across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics reflect differing clinical infrastructures, regulatory regimes, and procurement behaviors that influence product adoption and commercial strategies. In the Americas, advanced clinical laboratories and centralized testing networks drive demand for high-throughput automatic systems with strong after-sales support and integration capabilities. The region's emphasis on rapid innovation cycles and digital health adoption creates opportunities for solutions that emphasize connectivity, analytics, and lifecycle services to maximize uptime and efficiency.

Across Europe, the Middle East and Africa, stakeholders face a mosaic of regulatory frameworks and funding models that favor versatile solutions able to comply with stringent standards in some markets while remaining cost-effective in others. Public health institutions and centralized reference labs in parts of this region demand validated systems that align with national screening and blood safety programs, while emerging markets within the region require durable, low-maintenance machines suited to constrained operational environments.

In the Asia-Pacific region, rapid healthcare infrastructure expansion and strong manufacturing ecosystems combine with cost-conscious procurement to create a dual dynamic of accelerating adoption and fierce price competition. Hospitals and diagnostic laboratories in major urban centers seek advanced automation and digital features, whereas remote and regional facilities prioritize robustness, serviceability, and simplified operation. Together, these regional trends guide manufacturers in tailoring distribution models, local service footprints, and product feature sets to meet heterogeneous demand profiles.

Insightful company-level analysis focusing on differentiation through integrated solutions, service excellence, partnerships, and intellectual property strategies

Competitive dynamics in the sector center on differentiated product portfolios, service depth, and the ability to deliver integrated workflows rather than standalone equipment. Leading manufacturers compete on the strength of validated integrations with laboratory analyzers and information systems, demonstrated field reliability, and responsive aftermarket services including installation, preventive maintenance, and spare parts logistics. Strategic alliances with consumable suppliers and contract manufacturers enable faster time-to-market for new device variants, while investments in intellectual property around sensor technologies, sample handling algorithms, and software validation create defensible positions.

Smaller and niche players find avenues to compete through targeted innovation, such as specialized modules for forensic traceability or research-grade configurability, and by offering flexible commercial models like pay-per-use service agreements and bundled consumable subscriptions. Mergers and partnerships continue to shape the competitive landscape as firms seek complementary capabilities in digital health, manufacturing scale, or geographic reach. Ultimately, long-term competitiveness depends on the ability to combine product performance, digital services, certified quality systems, and a resilient supply chain to meet the evolving priorities of clinical and laboratory customers.

Practical and prioritized recommendations for manufacturers and buyers to enhance interoperability, supply chain resilience, service models, regulatory readiness, and sustainability outcomes

Industry leaders should pursue a set of pragmatic, high-impact actions that align product development with operational realities and buyer expectations. Prioritize investments in interoperability and secure data exchange to ensure devices integrate smoothly with laboratory information systems and downstream analytics platforms, which enhances value for high-throughput laboratories and hospital networks. Simultaneously, diversify manufacturing and sourcing strategies to reduce exposure to tariff-related cost volatility and to shorten lead times for critical components and spare parts. This dual focus on connectivity and supply resilience will reduce procurement friction and improve long-term competitiveness.

Adopt service-led commercial models that bundle preventive maintenance, validated consumables, and rapid-response field support, thereby shifting customer conversations from upfront cost to predictable total cost of ownership. Develop modular product architectures that allow rapid reconfiguration between vacuum and non-vacuum tube workflows and that accommodate mechanical, optical, or pressure sensing modules according to end-user needs. Engage proactively with regulatory bodies to clarify expectations for software validation, cybersecurity, and post-market surveillance; early alignment reduces time-to-adoption and mitigates compliance risk. Finally, commit to sustainability initiatives that reduce single-use waste and demonstrate supplier transparency, because environmental performance increasingly influences procurement decisions in both public and private sectors.

Transparent description of the mixed-methods research approach combining expert interviews, standards review, supply chain mapping, and validation workshops to ensure robust findings

The research approach blended qualitative and quantitative techniques to produce a comprehensive view of the technology, procurement, and operational landscapes. Primary research included structured interviews with laboratory directors, blood bank managers, hospital procurement officers, device engineers, and regulatory experts to surface practical constraints, validation requirements, and deployment preferences. Secondary analysis incorporated product literature, standards documentation, clinical guidelines, and publicly available regulatory rulings to contextualize device design choices and post-market obligations.

Data triangulation ensured that insights reflected convergent evidence from multiple sources, including device specification comparisons, warranty and service contract analyses, and supply chain mapping exercises. Validation workshops with subject-matter experts refined conclusions and highlighted practical deployment considerations such as installation footprint, consumables logistics, and training needs. Limitations of the methodology include spatial variability in regulatory enforcement and the evolving nature of digital health standards; therefore, stakeholders should treat findings as a strategic guide and complement them with targeted local validations and pilot implementations where appropriate. The research process followed rigorous documentation and reproducibility practices to support client-specific customization requests.

Concise concluding synthesis emphasizing strategic imperatives for product alignment, interoperability, supply resilience, and phased deployment to maximize clinical impact

In summary, blood collection tube machines constitute a critical enabler of safe, efficient, and traceable specimen workflows across clinical diagnostics, blood banking, forensic analysis, and research applications. Device selection now requires a nuanced assessment that balances automation level, sensing technology, tube compatibility, interoperability, and service assurance. Regional and application-specific differences underscore the importance of tailored product offerings and flexible commercial models that address both high-volume centralized laboratories and decentralized clinical environments.

Looking ahead, manufacturers and procurement teams that align product development with digital integration, regulatory expectations, and resilient supply chain strategies will be best positioned to meet evolving clinical needs. Proactive engagement on sustainability and lifecycle support will also create competitive differentiation. Decision-makers should prioritize pilots and phased rollouts to validate interoperability, staff training, and consumables logistics before scaling deployments, thereby minimizing operational disruption and maximizing clinical value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Tube Machines Market, by Operation Mode

  • 8.1. Automatic
  • 8.2. Semi Automatic

9. Blood Collection Tube Machines Market, by Technology

  • 9.1. Mechanical
  • 9.2. Optical
  • 9.3. Pressure

10. Blood Collection Tube Machines Market, by Tube Type

  • 10.1. Non Vacuum
  • 10.2. Vacuum

11. Blood Collection Tube Machines Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals

12. Blood Collection Tube Machines Market, by Application

  • 12.1. Clinical Diagnostics
  • 12.2. Forensic
  • 12.3. Research

13. Blood Collection Tube Machines Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Collection Tube Machines Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Collection Tube Machines Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Blood Collection Tube Machines Market

17. China Blood Collection Tube Machines Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Ajosha Bio Teknik Pvt. Ltd.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Biomall
  • 18.9. Bio-x Diagnostics
  • 18.10. CDRICH Corporation
  • 18.11. CML Biotech Ltd.
  • 18.12. Danaher Corporation
  • 18.13. Gong Dong Medical
  • 18.14. GPC Medical, Ltd.
  • 18.15. Hawach Scientific Co., Ltd.
  • 18.16. KS Medical
  • 18.17. Medtronic plc
  • 18.18. Narang Medical Limited
  • 18.19. Nipro Corporation
  • 18.20. Qiagen N.V.
  • 18.21. Quantum Biomedicals
  • 18.22. Roche Holding AG
  • 18.23. Sanli Medical
  • 18.24. Siemens Healthineers AG
  • 18.25. Sysmex Corporation
  • 18.26. Thermo Fisher Scientific Inc.
  • 18.27. TUD Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SEMI AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SEMI AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SEMI AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY NON VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY NON VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY NON VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY FORENSIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY FORENSIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY FORENSIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GCC BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. G7 BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NATO BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA BLOOD COLLECTION TUBE MACHINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)